For patients presenting with LDL-C >100 mg/dL, total cholesterol >200 mg/dL, or triglycerides >150 mg/dL — and anyone wondering whether they actually need medication, or whether lifestyle can do the job.
Here’s the strange thing about a high cholesterol diagnosis: nothing feels different afterward.
You walked into that appointment feeling fine. You walked out with a number on a piece of paper that apparently means something is wrong. No pain, no fatigue, no symptoms pointing you toward the problem. Just a lab result and a lot of unanswered questions.
That absence of symptoms is exactly what makes high cholesterol dangerous and exactly why catching it early matters as much as it does. Plaque buildup in your arteries is a decades long process. It doesn’t announce itself. It just accumulates, quietly, until one day it does.
Your diagnosis caught it in the quiet phase. That’s the whole point.
Part 1: The Pattern Behind the Diagnosis
What Your Numbers Actually Mean
This is the opening of a longer article.
The full piece — the mechanisms, the labs to ask for, and what to do about it — is free to read on our newsletter.
Sources & Research
Every claim in this article is grounded in peer-reviewed research. DOI links open the original studies.
Cholesterol Treatment Trialists’ (CTT) Collaboration. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet. 2010;376(9753):1670–1681. doi:10.1016/S0140-6736(10)61350-5
Handelsman Y et al. Gender disparities in LDL-C achievement and statin prescribing. Lipid analysis, 2025.
Jenkins DJA, Chiavaroli L et al. Portfolio Dietary Pattern and Cardiovascular Disease: a Systematic Review and Meta-analysis of Controlled Trials. Progress in Cardiovascular Diseases. 2018;61(1):54–69. doi:10.1016/j.pcad.2018.05.004
Grüneberg M et al. Effects of coenzyme Q10 supplementation on myopathy in statin-treated patients: a systematic review and meta-analysis. 2024. PMC12554813.
Liu Z, Tian Z, Zhao D et al. Effects of Coenzyme Q10 Supplementation on Lipid Profiles in Adults: A Meta-analysis of Randomized Controlled Trials. Journal of Clinical Endocrinology & Metabolism. 2023;108(1):232–249. doi:10.1210/clinem/dgac585
Roshanzamir S et al. Effects of coenzyme Q10 administration on blood pressure and heart rate in adults: a systematic review and meta-analysis of 45 randomized controlled trials. 2025.
Askarpour M et al. The effects of L-carnitine supplementation on lipid profiles in adults: A systematic review and dose-response meta-analysis of 60 randomized controlled trials. ScienceDirect. 2023.
Pirro M, Vetrani C, Bianchi C et al. Red Yeast Rice for Hypercholesterolemia: JACC Focus Seminar. Journal of the American College of Cardiology. 2021;77(5):620–628. doi:10.1016/j.jacc.2020.11.056
Righetti AA et al. Red Yeast Rice or Lovastatin? A Comparative Evaluation of Safety and Efficacy. Phytotherapy Research. 2024. PMC11745150.
Norata GD, Banach M. The Impact of Red Yeast Rice Extract Use on the Occurrence of Muscle Symptoms and Liver Dysfunction: An Update from the Adverse Event Reporting Systems and Available Meta-Analyses. Nutrients. 2024;16(3):444. doi:10.3390/nu16030444
Karampetsou N et al. Safety and Efficacy of the Consumption of Red Yeast Rice Extract for the Reduction of Hypercholesterolemia: A Systematic Review and Meta-Analysis of 14 clinical trials. Nutrients. 2024;16(10):1453. doi:10.3390/nu16101453
Glenn AJ et al. Portfolio Diet Score and Risk of Cardiovascular Disease: Findings From 3 Prospective Cohort Studies. Circulation. 2023. doi:10.1161/CIRCULATIONAHA.123.065551
